From the Journals

Dealing with life-threatening asthma attacks


 

FROM CHEST

Ventilation in life-threatening asthma

Rapid sequence intubation is generally recommended for patients who require mechanical ventilation, but as an alternative, “we are advocating a slower approach, where we get patients to slow down their breathing and relax them with something like ketamine infusions and wait before we given them a paralytic to see if the work of breathing improves,” Dr. Garner said. Bag-mask ventilation should be avoided because it can worsen dynamic hyperinflation or cause barotrauma.

Salvage therapies such as the use of bronchoscopy with N-acetylcysteine instilled directly into the airway is another option in cases in which mucus plugging is considered to be the main driver of airflow limitation.

Asked to comment, Brit Long, MD, an emergency medicine physician at the Brooke Army Medical Center in San Antonio, Tex., felt the review was extremely useful and well done.

“We see these patients very frequently, and being able to assess them right away and get an accurate picture of what’s going on is very important,” he said in an interview. The one thing that is often more difficult, at least in the ED, is obtaining a PEF or the FEV1 – “both very helpful if the patient can do them, but if the patient is critically ill, it’s more likely you will not be able to get those assessments, and if patients are speaking in one-word sentences and are working really hard to breathe, that’s a severe exacerbation, and they need immediate intervention.” Dr. Long also liked all the essential treatments the authors recommended that patients be given immediately, although he noted that Heliox is not going to be available in most EDs.

On the other hand, he agreed with the authors’ recommendation to take a slower approach to mechanical ventilation, if it is needed at all. “I try my best to absolutely avoid intubating these patients – you are not fixing the issue with mechanical ventilation, you are just creating further problems.

“And while I see the entire spectrum of asthma patients from very mild to severe patients, these authors did a good job in explaining what the goals of treatment are and what to do with the severe ones,” he said.

Dr. Garner and Dr. Long disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Pneumonia in infancy predicts respiratory problems in early childhood
MDedge Family Medicine
Peanut oral immunotherapy is safe and effective in toddlers in large placebo-controlled trial
MDedge Family Medicine
Omalizumab curbs airway inflammation in severe asthma
MDedge Family Medicine
Infant bronchiolitis subtype may predict asthma risk
MDedge Family Medicine
Needle-free epinephrine products could be available in 2023
MDedge Family Medicine
Azithromycin doesn’t prevent recurrent wheezing after acute infant RSV
MDedge Family Medicine
Asthma: Easy strategy reduces exacerbations, improves control
MDedge Family Medicine
New gene signals for asthma-COPD overlap identified
MDedge Family Medicine
Digital monitors can relieve asthma burden by boosting medication adherence and inhaler technique
MDedge Family Medicine
FDA approves generic Symbicort for asthma, COPD
MDedge Family Medicine